Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions

BACKGROUND: ABL-class fusions including NUP214-ABL1 and EBF1-PDGFRB occur in high risk acute lymphoblastic leukaemia (ALL) with gene expression patterns similar to BCR-ABL-positive ALL. Our aim was to evaluate new DNA-based measurable residual disease (MRD) tests detecting these fusions and IKZF1-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Venn, Nicola C., Huang, Libby, Hovorková, Lenka, Muskovic, Walter, Wong, Marie, Law, Tamara, Heatley, Susan L., Khaw, Seong Lin, Revesz, Tom, Dalla Pozza, Luciano, Shaw, Peter J., Fraser, Chris, Moore, Andrew S., Cross, Siobhan, Bendak, Katerina, Norris, Murray D., Henderson, Michelle J., White, Deborah L., Cowley, Mark J., Trahair, Toby N., Zuna, Jan, Sutton, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427854/
https://www.ncbi.nlm.nih.gov/pubmed/35650277
http://dx.doi.org/10.1038/s41416-022-01806-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427854/
https://www.ncbi.nlm.nih.gov/pubmed/35650277
http://dx.doi.org/10.1038/s41416-022-01806-6

Ejemplares similares